Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2011
Mar. 31, 2011
Current assets    
Cash $ 354,804 $ 15,704
Deferred financing costs 193,749 157,732
Accounts receivable 183,367  
Note receivable   200,000
Interest receivable   7,096
Prepaid expenses and other current assets 26,250 29,711
Total current assets 758,170 410,243
Property and equipment, net 2,535 7,785
Patents and patents pending, net 133,108 139,981
Deposits 9,210 9,210
Total assets 903,023 567,219
Current Liabilities    
Accounts payable 634,082 308,413
Due to related parties 617,570 617,570
Notes payable 584,796 190,000
Convertible notes payable, net of discounts 2,462,825 2,181,852
Derivative liabilities 1,250,705 2,002,896
Accrued liquidated damages 437,800 437,800
Other current liabilities 1,022,436 804,386
Total current liabilities 7,010,214 6,542,917
Commitments and Contingencies (Note 12)      
Stockholders' Deficit    
Common stock, par value $0.001 per share; 250,000,000 shares authorized as of December 31, 2011 and March 31, 2011; 108,977,508 and 77,467,361 shares issued and outstanding as of December 31, 2011 and March 31, 2011, respectively 108,980 77,469
Additional paid-in capital 45,869,870 42,418,778
Deficit accumulated (52,086,041) (48,471,945)
Total stockholders’ deficit (6,107,191) (5,975,698)
Total liabilities and stockholders' deficit $ 903,023 $ 567,219